How has been the historical performance of Evexia Lifecare?

Answer:The historical performance of Evexia Lifecare shows significant fluctuations in key financial metrics over the years. Breakdown: Evexia Lifecare's net sales have seen a notable increase from INR 56.29 crore in March 2024 to INR 110.48 crore in March 2025, following a dip from INR 69.55 crore in March 2023 and INR 75.51 crore in March 2022. The total operating income mirrored this trend, rising to INR 110.48 crore in March 2025 from INR 56.29 crore in March 2024. The total expenditure, excluding depreciation, also increased to INR 106.40 crore in March 2025 from INR 54.31 crore in March 2024. Operating profit (PBDIT) improved to INR 4.22 crore in March 2025 from INR 2.85 crore in March 2024, while profit before tax decreased slightly to INR 1.44 crore in March 2025 from INR 1.93 crore in March 2024. The profit after tax also declined to INR 0.93 crore in March 2025 from INR 1.38 crore in March 2024. On the balance sheet, total assets rose to INR 883.00 crore in March 2024 from INR 847.50 crore in March 2023, with total liabilities increasing to INR 883.00 crore in March 2024 from INR 847.50 crore in March 2023. The cash flow from operating activities showed a positive shift to INR 17.00 crore in March 2024 from a negative INR 3.00 crore in March 2023, while cash flow from investing activities turned negative at INR -17.00 crore in March 2024, indicating significant investment activity. Overall, Evexia Lifecare's financial performance reflects a recovery in sales and operating profit, despite some declines in net profit and ongoing fluctuations in cash flow.